Mangrove Partners’s Chimerix, Inc. CMRX Stock Holding History

Mangrove Partners’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,018,181	Closed	-$4.66M	–	536
2022 Q1	$4.66M	Buy	+1,018,181	New	+$5.67M	0.25%	125

Other funds holding CMRX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners's CMRX Position: Q2 2022 in Review

Mangrove Partners sold out of Chimerix, Inc. (CMRX) in Q2 2022, closing a stake of 1,018,181 shares — an estimated $4.66M sold.

Mangrove Partners first reported a position in CMRX in Q1 2022 and held it in 1 quarter. The position peaked at $4.66M in Q1 2022. 117 funds tracked by Wall St. Rank hold CMRX as of Q2 2022.

Mangrove Partners reported no remaining Chimerix, Inc. position as of Q2 2022 after selling out during the quarter.
Mangrove Partners sold 1,018,181 Chimerix, Inc. shares in Q2 2022, an estimated $4.66M.
Mangrove Partners first reported a position in Chimerix, Inc. in Q1 2022 and held it in 1 quarter.
Mangrove Partners's Chimerix, Inc. position peaked at $4.66M in Q1 2022.
117 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2022.

Based on Mangrove Partners's 13F filing for Q2 2022, filed 15 Aug 2022.